The pre-clinical absorption, distribution, metabolism and excretion properties of IPI-926, an orally bioavailable antagonist of the hedgehog signal transduction pathway (Q86487394)
Jump to navigation
Jump to search
scientific article published on 25 March 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The pre-clinical absorption, distribution, metabolism and excretion properties of IPI-926, an orally bioavailable antagonist of the hedgehog signal transduction pathway |
scientific article published on 25 March 2013 |
Statements
The pre-clinical absorption, distribution, metabolism and excretion properties of IPI-926, an orally bioavailable antagonist of the hedgehog signal transduction pathway (English)
Sherri Smith
Jennifer Hoyt
Nigel Whitebread
Joseph Manna
Marisa Peluso
Kerrie Faia
Veronica Campbell
Martin Tremblay
Somarajan Nair
Michael Grogan
Alfredo Castro
Matthew Campbell
Jeanne Ferguson
Brendan Arsenault
Jylle Nevejans
Bennett Carter
John Lee
Joi Dunbar
Karen McGovern
Margaret Read
Julian Adams
Alexander Constan
Gordon Loewen
Jens Sydor
Vito Palombella
John Soglia
25 March 2013